90岁及以上患者髋部骨折术后早期死亡的预测:阿尔梅洛髋部骨折评分90(AHFS90)
本研究纳入922例90岁及以上接受髋部骨折手术的患者,开发并内部及外部验证了预测术后30天内早期死亡的AHFS90评分。该评分包含年龄、性别、痴呆、养老院居住、ASA评分和血红蛋白水平,在地理交叉验证中曲线下面积为0.72,多数风险分组的预测风险与观察风险相符,但在两个风险分组中高估风险,在一个风险分组中无死亡发生而无法分析。
要点
- AHFS90评分用于预测90岁及以上髋部骨折术后早期死亡,包含年龄、性别、痴呆、养老院居住、ASA评分和血红蛋白水平。
- 922例患者中102例(11.1%)在术后30天内死亡,AHFS90在地理交叉验证中曲线下面积为0.72。
- 多数风险分组的预测风险与观察风险相符,两个风险分组高估风险,一个风险分组无死亡发生而无法分析。
核心结论
- AHFS90能准确预测90岁及以上患者髋部骨折术后早期死亡,多数风险分组的预测风险与观察风险相符,在本研究人群中最大预测早期死亡风险为64.5%。
研究设计与样本
- 纳入90岁及以上接受髋部骨折手术的患者,对缺失数据采用链式方程多重插补,使用逻辑回归开发AHFS90并进行内部和外部验证,通过校准图及比较观察与预测风险评估校准。
主要发现
- 922例患者中102例(11.1%)在髋部骨折术后30天及以内死亡。
- AHFS90在地理交叉验证中曲线下面积为0.72。
- 在四个风险分组中预测风险与观察早期死亡风险相符,在两个风险分组中AHFS90高估风险,在一个风险分组中未观察到死亡而无法分析。
- 在本研究人群中AHFS90对早期死亡的最大预测值为64.5%。
关键数值与推荐
- AHFS90包含年龄、性别、痴呆、养老院居住、ASA评分和血红蛋白水平作为早期死亡的预测因子。
临床怎么用
- 原文未据此给出推荐。
局限性
- 在一个风险分组中未观察到死亡,因此无法进行分析。
- 在两个风险分组中AHFS90高估了风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The AHFS90 was developed for the prediction of early mortality in patients ≥ 90 years undergoing hip fracture surgery. The AHFS90 has a good accuracy and in most risk categories a good calibration. In our study population, the AHFS90 yielded a maximum prediction of early mortality of 64.5%. PURPOSE: Identifying hip fracture patients with a high risk of early mortality after surgery could help make treatment decisions and information about the prognosis. This study aims to develop and validate a risk score for predicting early mortality in patients ≥ 90 years undergoing hip fracture surgery (AHFS90). METHODS: Patients ≥ 90 years, surgically treated for a hip fracture, were included. A selection of possible predictors for mortality was made. Missing data were subjected to multiple imputations using chained equations. Logistic regression was performed to develop the AHFS90, which was internally and externally validated. Calibration was assessed using a calibration plot and comparing observed and predicted risks. RESULTS: One hundred and two of the 922 patients (11.1%) died ≤ 30 days following hip fracture surgery. The AHFS90 includes age, gender, dementia, living in a nursing home, ASA score, and hemoglobin level as predictors for early mortality. The AHFS90 had good accuracy (area under the curve 0.72 for geographic cross validation). Predicted risks correspond with observed risks of early mortality in four risk categories. In two risk categories, the AHFS90 overestimates the risk. In one risk category, no mortality was observed; therefore, no analysis was possible. The AHFS90 had a maximal prediction of early mortality of 64.5% in this study population. CONCLUSION: The AHFS90 accurately predicts early mortality after hip fracture surgery in patients ≥ 90 years of age. Predicted risks correspond to observed risks in most risk categories. In our study population, the AHFS90 yielded a maximum prediction of early mortality of 64.5%.
引用
- Nijmeijer WS, Voorthuis BJ, Groothuis-Oudshoorn CGM, et al. The prediction of early mortality following hip fracture surgery in patients aged 90 years and older: the Almelo Hip Fracture Score 90 (AHFS90). Osteoporos Int. 2023. PMID: 36856794. doi:10.1007/s00198-023-06696-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。